First Wave BioPharma CEO James Sapirstein to Present at the 2023 Roth Healthcare Opportunities Conference - First Wave BioPharma (NASDAQ:FWBI)
BOCA RATON, Fla., Oct. 03, 2023 (GLOBE NEWSWIRE) -- First Wave BioPharma, Inc., (NASDAQ:FWBI), ("First Wave BioPharma" or the "Company"), a clinical-stage biopharmaceutical company specializing in the development of